Hedge-fund manager Leon Cooperman is opposing the company's $490 million acquisition by Tower Group (TWGP). Cooperman wants the company to share its analysis showing how this transaction is fair to CPHL shareholders. "Just show me I am wrong, and I will go along with the transaction quietly," Cooperman says, suggesting that the Tower Group sweeten the package with a warrant that adds some $2 a share in value. Cooperman owns 2,750,500 shares (7.2% of the total outstanding).

Riley Investment Management entered into a settlement with the company. Under it, Zilog will expand its board to six directors, with Eric Singer named as a Class III director. Upon his appointment, Singer will assume a seat on the board's compensation committee, and Zilog will include him on its slate for election as a Class III director at the 2008 annual meeting. Riley, in turn, will withdraw its nomination letter and vote in favor of the board's slate at the 2008 and 2009 meetings. Riley holds 1,408,907 shares (8.3%).

Jasmine Holdco is evaluating possible transactions with the Israel-based information-security company. Jasmine's representative met briefly with Aladdin's management recently to inquire about a sale of the company's software digital-management rights business and was told that the company had no interest in a sale. Aladdin is evaluating whether to encourage the company to maximize shareholder value through a possible merger, sale of assets, or business combination, which may include a transaction with SafeNet, a Jasmine affiliate. Jasmine may also seek representation on the company's board. Jasmine Holdco reported ownership of 1,269,300 shares (9.14%).

Doucet Capital wants RF Monolithics to put itself up for sale. Doucet argues that RF's stock is "undervalued by a multiple of its current trading price." It also contends that management and officers "have been too slow to adjust to market conditions and make the changes necessary to right-size their business." Doucet Capital reported holding 457,572 shares (5%).

Marlin Sams Fund reported holding 450,000 shares (5.7%). Marlin Sams says that it acquired its stake for investment purposes, and may engage in communications with one or more stockholders, management or members of the board about business and financial strategies.

Small Ventures USA raised its stake to about 2.85 million shares (8.8%) from the 2.41 million (7.4%) reported on Aug 7. Small Ventures previously had said it planned to discuss a buyout of NCOC, contingent on management's participation, because it believed the stock "undervalued."

Investment funds controlled by investor Carl Icahn raised their stake to 17.5 million shares (6.03%) from the 12.4 million (4.24%) reported on March 31. Icahn, who lost a proxy fight with Biogen, says that he may seek to continue discussions with the company.

Jana Partners raised its position to 12.7 million shares (10.4%), by buying 506,504 from Aug. 6 to 8 at an average price of $13.23. Last month, Jana said that it hoped to engage in "constructive dialogues" with the company, in the hope of boosting shareholder value.